A longitudinal study involving nearly 13,000 participants has identified a significant correlation between the high consumption of several widely used low-calorie sweeteners and a more rapid deterioration of memory and executive function. The research, published in the medical journal Neurology, the official publication of the American Academy of Neurology, suggests that the "health halo" surrounding sugar-free alternatives may be masking potential long-term risks to neurological health. Led by researchers at the University of São Paulo, the study tracked adult participants over an eight-year period, revealing that those with the highest intake of these substitutes experienced cognitive aging equivalent to an additional 1.6 years compared to those with the lowest intake.
The findings come at a time when global consumption of non-sugar sweeteners (NSS) is at an all-time high, driven by public health efforts to reduce obesity and type 2 diabetes by limiting refined sugar intake. However, the study’s authors, including lead author Dr. Claudia Kimie Suemoto, suggest that these alternatives may not be the inert substances they were once thought to be. While the study was observational and does not prove direct causation, the strength of the association—particularly among younger middle-aged adults and those with pre-existing metabolic conditions—has prompted calls for a more cautious approach to ultra-processed "diet" foods.
The Scope and Methodology of the ELSA-Brasil Study
The research utilized data from the Longitudinal Study of Adult Health (ELSA-Brasil), a massive cohort study designed to investigate the development and progression of chronic diseases in Brazilian adults. For this specific analysis, researchers focused on 12,772 individuals with an average age of 52 at the start of the observation period. The demographic was diverse, representing a broad cross-section of the professional workforce in six Brazilian cities.
At the beginning of the study, participants underwent a rigorous baseline assessment that included comprehensive food frequency questionnaires. These surveys required individuals to detail their consumption habits over the previous 12 months, specifically identifying their intake of products containing seven specific sweeteners: aspartame, saccharin, acesulfame K, erythritol, xylitol, sorbitol, and tagatose. These ingredients are ubiquitous in the modern food supply, found in everything from sugar-free sodas and flavored waters to "diet" yogurts, protein bars, and tabletop sweeteners used in coffee and tea.
To track cognitive health, the research team administered a battery of standardized tests at three distinct intervals: at the study’s inception, at a midpoint, and at the eight-year conclusion. These assessments focused on three critical domains of brain function:
- Verbal Fluency: The ability to retrieve information quickly from the lexicon, often tested by asking participants to name as many words as possible within a specific category in one minute.
- Working Memory: The short-term system responsible for temporarily holding and processing information, vital for reasoning and decision-making.
- Processing Speed: The time it takes for a person to perceive information, process it, and provide a response.
Quantifying the Impact: A Tiered Analysis of Consumption
Participants were categorized into three groups based on their total daily sweetener intake. The "low consumption" group averaged approximately 20 milligrams per day (mg/day), a negligible amount often found in occasional snacks or lightly sweetened beverages. The "middle consumption" group showed a moderate increase, while the "high consumption" group averaged 191 mg/day.
To put these numbers into a practical context, the researchers noted that the high-consumption threshold for aspartame was roughly equivalent to the amount found in a single 12-ounce can of diet soda. This suggests that even "moderate" consumers by modern standards—those who drink one diet soft drink daily—could fall into the highest risk category identified by the study. Among the individual sweeteners, sorbitol was the most heavily consumed, with an average daily intake of 64 mg/day across the study population.
The results revealed a clear dose-response relationship. After adjusting for variables such as age, sex, education level, smoking status, physical activity, and cardiovascular health markers like hypertension, the data showed:
- High Intake Group: Experienced a 62% faster decline in global cognitive scores compared to the low-intake group. This was statistically interpreted as being equivalent to 1.6 additional years of brain aging.
- Middle Intake Group: Experienced a 35% faster decline than the low-intake group, equivalent to approximately 1.3 years of accelerated aging.
Age and Diabetes: Identifying High-Risk Subgroups
One of the more unexpected findings of the research was the role of age in the association between sweeteners and brain health. The link was significantly more pronounced in participants under the age of 60. In this younger cohort, high sweetener consumption was strongly tied to faster declines in both verbal fluency and overall cognitive performance. Conversely, the association was not statistically significant for participants who were already over the age of 60 at the start of the study.
This discrepancy suggests that the middle-age window may be a critical period for neurological vulnerability to dietary additives. It also raises questions about the cumulative effects of these substances over decades of use, as younger generations have been exposed to artificial sweeteners from an earlier age than their older counterparts.
Furthermore, the study highlighted a heightened risk for individuals with diabetes. This group often relies heavily on sugar substitutes to manage glycemic levels. However, the researchers found that the association between sweetener intake and cognitive decline was markedly stronger in diabetics than in non-diabetics. This creates a clinical paradox: the very substances used to manage one chronic condition (diabetes) may potentially accelerate the progression of another (cognitive impairment).
A Breakdown of the Seven Sweeteners
The study did not find a uniform risk across all substances tested. When analyzed individually, six of the seven sweeteners were linked to faster cognitive decline, particularly in the realm of memory. These included:
- Aspartame: One of the most studied and controversial sweeteners, commonly found in blue packets and diet sodas.
- Saccharin: The oldest artificial sweetener, often found in pink packets.
- Acesulfame K: Frequently used in combination with other sweeteners to mask bitter aftertastes.
- Erythritol: A sugar alcohol that has recently gained popularity in "keto-friendly" and "low-carb" baked goods.
- Sorbitol and Xylitol: Sugar alcohols often used in sugar-free gums, mints, and liquid medications.
The outlier in the study was tagatose, a rare functional sweetener that is structurally similar to fructose but has a lower caloric value. Tagatose was the only substance in the study that showed no association with cognitive decline. Researchers suggested this might be due to its different metabolic pathway or its lower prevalence in the participants’ diets, though more focused research is required to determine if tagatose could serve as a safer alternative.
Scientific Context and Potential Mechanisms
While the ELSA-Brasil study was not designed to identify the biological mechanisms behind these findings, the scientific community has proposed several theories. One leading hypothesis involves the "gut-brain axis." Artificial sweeteners are known to alter the composition of the gut microbiome. A dysbiotic gut environment can lead to systemic inflammation, which has been closely linked to neuroinflammation and the development of neurodegenerative diseases.
Another theory concerns metabolic confusion. Some studies suggest that the intense sweetness of these substitutes, unaccompanied by the expected calories, may disrupt the brain’s ability to regulate appetite and glucose metabolism. This could lead to subtle insulin resistance in the brain—a condition sometimes referred to as "Type 3 Diabetes"—which is a known driver of cognitive decline.
Industry and Regulatory Implications
The publication of this study adds to a growing body of evidence questioning the long-term safety of non-sugar sweeteners. In 2023, the World Health Organization (WHO) issued a conditional recommendation against the use of NSS for weight control, citing potential links to increased risks of type 2 diabetes and cardiovascular diseases.
While the International Sweeteners Association and various food industry groups frequently point to the regulatory approvals granted by the FDA and EFSA (European Food Safety Authority), these approvals are often based on acute toxicity rather than long-term neurological impacts. The findings from the University of São Paulo may encourage regulatory bodies to re-evaluate the "Generally Recognized as Safe" (GRAS) status of certain additives in the context of brain health and aging.
Limitations and the Path Forward
The researchers were careful to note several limitations. Because the dietary data was self-reported through questionnaires, it is subject to recall bias; participants may have underestimated their intake of processed foods. Additionally, as an observational study, it cannot account for "reverse causality"—the possibility that people already experiencing subtle cognitive changes might change their diets in ways that include more sugar substitutes.
Furthermore, the study did not include newer sweeteners like monk fruit or stevia, which are increasingly common in the North American and European markets. As such, the findings cannot be generalized to all sugar alternatives.
Dr. Suemoto emphasized that while the results are concerning, they should serve as a catalyst for more rigorous, controlled clinical trials. "Our findings suggest that we need to be more critical of the ‘healthy’ label applied to sugar-free products," she stated. "Until we have more definitive data, opting for whole, unprocessed foods and natural flavorings may be the most prudent path for those concerned about their long-term brain health."
The study concludes that for those looking to reduce sugar intake, the best alternative may not be a chemical substitute but rather a gradual reduction in the preference for sweet tastes altogether, or the use of whole-food alternatives like fruit purees, though these too require further comparative study. As the global population ages and the prevalence of dementia rises, understanding the impact of common dietary additives on the brain remains a paramount public health priority.
